No Data
No Data
Oppenheimer Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $192
Earnings Preview: NBIX to Report Financial Results Post-market on May 05
BofA Securities Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Maintains Target Price $179
CCORF Maintains Neurocrine Biosciences(NBIX.US) With Buy Rating, Cuts Target Price to $158
Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?
Neurocrine Price Target Cut to $158.00/Share From $163.00 by Canaccord Genuity